Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Interaction Study of Fimasartan/Amlodipine and Hydrochlorothiazide
NCT03390465Phase 1Completed
- Sponsor
- Boryung
- Start
- Dec 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fimasartan in hypertension (HTN) (6 arms), sponsored by Boryung. Primary endpoint: Maximum Plasma Concentration. Started Dec 2017; status: completed.
02
Drugs
fimasartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03390465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03390465.